Lantheus Medical Imaging Initiates Phase 3 Clinical Trial Of Flurpiridaz F 18 For The Detection Of Coronary Artery Disease
Links shared publicly online about this topic.
- 178total visits
Lantheus Medical Imaging Initiates Phase 3 Clinical Trial Of Flurpiridaz F 18 For The Detection Of Coronary Artery Disease
Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic imaging, today announced the initiation of the first of two Phase 3 clinical trials to assess myocardial perfusion using Positron E
View full resource at medicalnewstoday.com
Tags: Circulation, Heart Disease, Circulatory Disorders, Coronary Artery Disease, Imaging Tests, Phase 3 Clinical Trial, Clinical Trial, Medical
Most Recently Shared on July 1, 2011 at 4:35 pm By:
MedicalNewsToday: Lantheus Medical Imaging Initiates Phase 3 Clinical Trial Of Flurpiridaz: http://bit.ly/lylq9d Full http://bit.ly/jvMxeD
Also Shared By:
Advertisement
MNT Clinical Trials
@mnt_clinical
Lantheus Medical Imaging Initiates Phase 3 Clinical Trial Of Flurpiridaz F 18 For The Detection Of Coronary Artery Dis... http://mnt.to/3XTY
1 year ago...